Herpes simplex virus 1 (HSV-1) for cancer treatment
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1007 · Cited by 687
Dingwell, K. S., Brunetti, C. R., Hendricks, R. L., Tang, Q., Tang, M., Rainbow, A. J., & Johnson, D. C. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.834-845.1994 · Cited by 337
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Koelle, D. M., & Corey, L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.96-113.2003 · Cited by 263
Gene Delivery Using Herpes Simplex Virus Vectors
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053864 · Cited by 92
Cited by
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,634
Optimizing oncolytic virotherapy in cancer treatment
Harrington, K., Freeman, D. J., Kelly, B., Harper, J., & Soria, J.-C. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0029-0 · Cited by 513
Oncolytic virotherapy: basic principles, recent advances and future directions
Lin, D., Shen, Y., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01407-6 · Cited by 459
Self-citationRehman, H., Silk, A. W., Kane, M. P., & Kaufman, H. L. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0158-5 · Cited by 362
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Bommareddy, P. K., Patel, A., Hossain, S., & Kaufman, H. L. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-016-0238-9 · Cited by 322
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
Zaimy, M. A., Saffarzadeh, N., Mohammadi, A., Pourghadamyari, H., Izadi, P., Sarli, A., Moghaddam, L. K., Paschepari, S. R., Azizi, H., Torkamandi, S., et al. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.16 · Cited by 289
Metal-Based Nanoparticles for the Treatment of Infectious Diseases
Aderibigbe, B. (2017) · Molecules · doi:10.3390/molecules22081370 · Cited by 269
Chen, X., Han, J., Chu, J., Zhang, L., Zhang, J., Chen, C., Chen, L., Wang, Y., Wang, H., Yi, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8526 · Cited by 242
“For example, its genomic structure is very stable, and adverse events in patients can be counteracted with effective antiviral drugs [8, 9].”
BackgroundProgress and problems with the use of suicide genes for targeted cancer therapy
Karjoo, Z., Chen, X., & Hatefi, A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.009 · Cited by 192
“, liver), potential for significant immune response to the viral capsid proteins, non-specific binding to all cells that overexpress coxsackie virus and adenovirus receptor (CAR), high costs of production and the fact that the majority of cancer cells do not express CAR have limited success of this vector in cancer ge…”
Geevarghese, S. K., Geller, D. A., de Haan, H. A., Hörer, M., Knoll, A. E., Mescheder, A., Nemunaitis, J., Reid, T. R., Sze, D. Y., Tanabe, K. K., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.020 · Cited by 163
“It has demonstrated selective antitumor activity in multiple cell lines in vitro and in vivo (Ghosh and Meyers, 1998; Carew et al., 1999; Kooby et al., 1999; Delman et al., 2000; McAuliffe et al., 2000; Cozzi et al., 2001; Shen and Nemunaitis, 2006; Friedman et al., 2009; Markert et al., 2009).”
Self-citationOncolytic herpes simplex virus engineering and preparation
Agarwalla, P. K., & Aghi, M. K. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-340-0_1 · Cited by 37
Metadata
- Authors
- Shen, Y., & Nemunaitis, J.
- Venue
- Cancer Gene Therapy
- Published
- 2006-04-07
- Volume
- 13
- Issue
- 11
- Pages
- 975-992
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- OpenAlex
- W2019034425
- Cited by
- 159
- References
- 4
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.